Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2026 08:45 ET | Source: Cemtrex Inc.

CEMTREX SUBSIDIARY, INVOCON, SELECTED FOR U.S. NAVY SBIR PHASE I CONTRACT IN NAVAL MINE WARFARE

CEMTREX SUBSIDIARY, INVOCON, SELECTED FOR U.S. NAVY SBIR PHASE I CONTRACT IN NAVAL MINE WARFARE
April 07, 2026 08:45 ET | Source: RedCloud Holdings plc

RedCloud Appoints Prof. Dr. Mustafa Ergen to Board as Non-Executive Director, Strengthening AI and Türkiye Expansion Strategy

London, UK, April 07, 2026 (GLOBE NEWSWIRE) -- RedCloud Holdings plc (Nasdaq: RCT) (“RedCloud” or the “Company”),, the company building intelligent infrastructure for global trade, today announced...
April 07, 2026 08:45 ET | Source: Vivos Therapeutics, Inc

Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners

Vivos Therapeutics Completes Private Placement with Existing Private Equity Investor, New Seneca Partners
April 07, 2026 08:45 ET | Source: Callan JMB Inc.

Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer

Reverse Distribution Coordination Delivered Necessary Medical Supplies to Requesting Jurisdictions through its Established Emergency Preparedness Network SPRING BRANCH, Texas, April 07, 2026 (GLOBE...
April 07, 2026 08:38 ET | Source: VivoPower PLC

VivoPower Appoints Former Microsoft Global AI Business Leader and G42 Executive, Khadija Mustafa, to Advisory Council

Ms. Mustafa brings a track record from a 23-year tenure at Microsoft, where she headed Global Sales & Partnerships for Industrial Metaverse Core, in the Cloud & AI division of Microsoft Based...
April 07, 2026 08:36 ET | Source: Moleculin Biotech, Inc.

Moleculin Releases Next CEO Corner Segment Highlighting Annamycin’s Non-Cardiotoxic Profile

Access the Moleculin CEO Corner here HOUSTON, April 07, 2026 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq: MBRX) (“Moleculin” or the “Company”), today announced it has released the next...
April 07, 2026 08:31 ET | Source: 20/20 Biolabs Inc.

20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform

20/20 BioLabs Selected by Evexia Diagnostics to Offer OneTest™ for Cancer Through Evexia Platform
April 07, 2026 08:31 ET | Source: Flux Power

Flux Power Advances Industry Leadership at MODEX 2026 with SkyEMS Enhancements, Sustainability Award Finalist Recognition, and Expert Panel Participation

VISTA, Calif., April 07, 2026 (GLOBE NEWSWIRE) -- Flux Power Holdings, Inc. (NASDAQ: FLUX), a leading developer of advanced lithium-ion energy storage solutions for material handling, airport ground...
April 07, 2026 08:31 ET | Source: Helport AI, Inc.

Helport AI Launches AI-Powered Collections Initiative with Leading Asian Consumer Finance Company

Helport AI launches AI-driven debt collection with Asian finance partner, showing early promise in recovery rates, engagement, and operational efficiency.
April 07, 2026 08:30 ET | Source: Xenon Pharmaceuticals Inc.

Xenon to Highlight Phase 3 X-TOLE2 & Long-Term Data for Azetukalner in Focal Onset Seizures at 2026 AAN Annual Meeting

Five abstracts accepted including Late-breaking Science oral and poster presentations of Phase 3 X-TOLE2 study results for azetukalner in focal onset seizures Poster presentations also include...